|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 111.8 INR | +0.56% |
|
+0.63% | +23.35% |
| 05-30 | Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets | MT |
| 05-13 | Alembic Limited Recommends Dividend for the Year Ended 31 March, 2024 | CI |
Alembic Ltd. announced at its meeting held on August 13, 2014, has appointed Mr. Rasesh Shah as Chief Financial Officer of the Company with effect from August 13, 2014.
| 1st Jan change | Capi. | |
|---|---|---|
| +23.35% | 344M | |
| +27.40% | 25.58B | |
| +13.54% | 24.49B | |
| -5.18% | 24.25B | |
| -20.01% | 23.68B | |
| +29.70% | 19.8B | |
| +3.54% | 19.73B | |
| -1.60% | 18.98B | |
| +46.90% | 17.94B | |
| -11.52% | 14.3B |
ALEMBIC LIMITED 
